Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kiadis Pharma Netherlands BV

Latest From Kiadis Pharma Netherlands BV

Tech Transfer Roundup: OncoSec Will Investigate CAR-T In Breast Cancer With Dana-Farber

Building on research by Dana-Farber professor Wayne Marasco, the partners are backing a bispecific approach to CAR-Ts in solid tumors. Seelos licenses a Parkinson’s gene therapy candidate from Duke.

Deals Business Strategies

Finance Watch: Third Rock Raises $770m To Launch Up To 12 New Companies

The VC firm known for its new company formation efforts will launch 10-12 biopharma, device and diagnostic ventures with its fifth fund. Also, EpimAb raises a $74m series B round, three more drug developers join the IPO queue and Amicus leads recent follow-on offerings.

Financing StartUps and SMEs

Kiadis Raises €28m As Cell Therapy Nears Commercialization

The funding comes as the Dutch biotech closes in on a potential conditional approval and closure of its acquisition of CytoSen.

Financing ImmunoOncology

Kiadis Still Betting On Blood Cancer Immunotherapy Launch This Year

Kiadis has conducted further analyses of data on its investigational blood cancer therapy ATIR101 and is now hoping to secure EU approval in time for the therapy to be used in the first patients by the end of 2019.

Drug Review Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Kiadis BV
  • Screentec BV
  • Kiadis Pharma BV
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • Kiadis Pharma Netherlands BV
  • Senior Management
  • Arthur Lahr, PhD, CEO
    Scott A Holmes, CFO
    Dirk de Naeyer, COO
    Andrew Sandler, MD, CMO
    Robert Friesen, PhD, CSO
  • Contact Info
  • Kiadis Pharma Netherlands BV
    Phone: (31) 20 314 02 50
    Paasheuvelweg 25A
    Amsterdam-Zuidoost, 1105 BP